Literature DB >> 8380817

Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor.

C A McNamara1, I J Sarembock, L W Gimple, J W Fenton, S R Coughlin, G K Owens.   

Abstract

Thrombin has been implicated in the stimulation of smooth muscle cell (SMC) proliferation that contributes to post angioplasty restenosis. The present studies demonstrated that human alpha-thrombin was a potent and efficacious mitogen for cultured rat aortic SMC, stimulating an increase in 3H-thymidine incorporation, as well as an increase in cell number at 1 to 10 nM concentration. gamma-Thrombin, which is enzymatically active but lacks fibrinogen clotting activity, stimulated SMC mitogenesis but was approximately 10-fold less potent than alpha-thrombin. In contrast, D-phenylalanyl-L-propyl-L-arginyl-chloromethyl ketone-alpha-thrombin, which lacked enzymatic activity, had no mitogenic effect. Diisopropylfluorophosphate-alpha-thrombin failed to stimulate mitogenesis except at concentrations having equivalent enzymatic activity as that of alpha-thrombin at its threshold for mitogenesis. Thus, thrombin-induced proliferation was dependent on enzymatic activity. A 14-residue peptide (SFLLRNPNDKYEPF) corresponding to amino acids 42 through 55 of the human thrombin receptor (Vu, T. K., D. T. Hung, V. I. Wheaton, and S. R. Coughlin, 1991. Cell. 64:1057-1068) had full efficacy in stimulating SMC proliferation. Reversing the first two amino acids of this peptide abolished mitogenic activity. Northern analysis demonstrated that SMC expressed a single mRNA species that hybridized to a labeled thrombin receptor cDNA probe. These findings indicate that alpha-thrombin stimulates SMC proliferation via the proteolytic activation of a receptor very similar or identical to that previously identified.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380817      PMCID: PMC330000          DOI: 10.1172/JCI116206

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization.

Authors:  U B Rasmussen; V Vouret-Craviari; S Jallat; Y Schlesinger; G Pagès; A Pavirani; J P Lecocq; J Pouysségur; E Van Obberghen-Schilling
Journal:  FEBS Lett       Date:  1991-08-19       Impact factor: 4.124

2.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro.

Authors:  R Ross; J Glomset; B Kariya; L Harker
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

3.  Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets.

Authors:  M G Davey; E F Lüscher
Journal:  Nature       Date:  1967-12-02       Impact factor: 49.962

4.  Human thrombins. Production, evaluation, and properties of alpha-thrombin.

Authors:  J W Fenton; M J Fasco; A B Stackrow
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

Review 5.  Thrombin inhibition by hirudin: how hirudin inhibits thrombin.

Authors:  J W Fenton; G B Villanueva; F A Ofosu; J M Maraganore
Journal:  Haemostasis       Date:  1991

6.  Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits.

Authors:  I J Sarembock; S D Gertz; L W Gimple; R M Owen; E R Powers; W C Roberts
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

7.  Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis.

Authors:  V Vouret-Craviari; E Van Obberghen-Schilling; U B Rasmussen; A Pavirani; J P Lecocq; J Pouysségur
Journal:  Mol Biol Cell       Date:  1992-01       Impact factor: 4.138

8.  Mitogenic activity of blood components. I. Thrombin and prothrombin.

Authors:  L B Chen; J M Buchanan
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

9.  Production of transforming growth factor beta 1 during repair of arterial injury.

Authors:  M W Majesky; V Lindner; D R Twardzik; S M Schwartz; M A Reidy
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

10.  Thrombin-induced events in non-platelet cells are mediated by the unique proteolytic mechanism established for the cloned platelet thrombin receptor.

Authors:  D T Hung; T H Vu; N A Nelken; S R Coughlin
Journal:  J Cell Biol       Date:  1992-02       Impact factor: 10.539

View more
  87 in total

Review 1.  How the protease thrombin talks to cells.

Authors:  S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Role of clot-associated (-derived) thrombin in cell proliferation induced by fibrin clots in vitro.

Authors:  E Gandossi; C Lunven; C N Berry
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

3.  Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries.

Authors:  P Zoldhelyi; Z Q Chen; H S Shelat; J M McNatt; J T Willerson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

4.  Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1.

Authors:  Claire J Chalmers; Kathryn Balmanno; Kathryn Hadfield; Rebecca Ley; Simon J Cook
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

5.  Exogenous thrombin delivery promotes collateral capillary arterialization and tissue reperfusion in the murine spinotrapezius muscle ischemia model.

Authors:  Anthony C Bruce; Shayn M Peirce
Journal:  Microcirculation       Date:  2012-02       Impact factor: 2.628

6.  Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

Authors:  J C Reverter; S Béguin; H Kessels; R Kumar; H C Hemker; B S Coller
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 7.  Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.

Authors:  Elisabeth MacColl; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2015-08-28       Impact factor: 4.030

8.  The role of protease-activated receptor-1 in bone healing.

Authors:  Shu Jun Song; Charles N Pagel; Therese M Campbell; Robert N Pike; Eleanor J Mackie
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

9.  Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development.

Authors:  S J Soifer; K G Peters; J O'Keefe; S R Coughlin
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

10.  Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin.

Authors:  D S Taylor; X Cheng; J E Pawlowski; A R Wallace; P Ferrer; C J Molloy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.